Publication | Closed Access
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience
25
Citations
16
References
2021
Year
Our study suggests no apparent reduction in efficacy when using a low-dosage nivolumab regimen.
| Year | Citations | |
|---|---|---|
Page 1
Page 1